[1]
A. L. Youseif, “Efficacy and Safety of Lower- versus Higher-Dose Baxdrostat in Adults with Resistant or Uncontrolled Hypertension, Including a CKD-Enriched Population: An Indirect Subgroup Comparison from Placebo-Controlled Trials — A Systematic Review and Meta-Analysis with GRADE Assessment”, ASIDE Endo, vol. 1, no. 1, pp. 1–9, Jun. 2026, doi: 10.71079/ASIDE.EN.06242026.